BIOMAT Database Logo BIOMAT Database Logo

Serum complement levels. 1984

R J Powell

The value of serum complement measurements to the clinician continues to increase as the intricate pathway is unravelled. These measurements are important in the investigation and monitoring of immunologically mediated diseases.

UI MeSH Term Description Entries
D007105 Immune Complex Diseases Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA. Hypersensitivity, Type III,Type III Hypersensitivity,Disease, Immune Complex,Diseases, Immune Complex,Hypersensitivities, Type III,Immune Complex Disease,Type III Hypersensitivities
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003240 Connective Tissue Diseases A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides. Connective Tissue Disease,Disease, Connective Tissue,Diseases, Connective Tissue
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R J Powell
[Serum complement levels in nephritis].
April 1967, Arerugi = [Allergy],
R J Powell
Serum complement levels in cerebral malaria.
March 1986, Indian pediatrics,
R J Powell
SERUM COMPLEMENT LEVELS IN HUMAN CANCER.
November 1964, Journal of the Philippine Medical Association,
R J Powell
Serum complement levels in malnourished children.
November 1979, The Indian journal of medical research,
R J Powell
[Serum complement levels in ulcerative colitis].
February 1980, Revista clinica espanola,
R J Powell
Serum complement levels and severity of sepsis.
May 1994, Research communications in chemical pathology and pharmacology,
R J Powell
[Serum complement levels in systemic lupus erythematosus].
March 1971, Arerugi = [Allergy],
R J Powell
Low serum complement levels in anorexia nervosa.
December 1989, American journal of diseases of children (1960),
R J Powell
Serum complement levels in the nephrotic syndrome.
November 1953, A.M.A. American journal of diseases of children,
R J Powell
Serum complement component levels in human glomerulonephritis.
October 1971, Annals of internal medicine,
Copied contents to your clipboard!